More on SPRY

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+44.2% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ARS Pharmaceuticals (NQ:SPRY)
Delayed: 5.82 +0.05 (0.87%)
Prev. Close $5.77  
Open$5.86 
52 Wk High$ 
52 Wk Low$ 
Day High$6.00 
Day Low$5.75 
P/E N/A  
EPS$ 
Volume1,196,979 


Sep 1, 2026 04:01 PM ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
Aug 25, 2026 07:03 PM Form 144 ARS Pharmaceuticals, Filed by: Lowenthal Richard E
Aug 25, 2026 09:09 AM Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar
Aug 24, 2026 08:04 AM Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Roblox Corporation (NYSE: RBLX); Symbotic Inc. (NASDAQ: SYM); and The Simply Good Foods Company (NASDAQ: SMPL):
Aug 20, 2026 05:32 PM Form 144 ARS Pharmaceuticals, Filed by: Tanimoto Sarina
Aug 20, 2026 04:26 PM Form 144 ARS Pharmaceuticals, Filed by: Lowenthal Richard E
Aug 19, 2026 04:21 PM Form 144 ARS Pharmaceuticals, Filed by: Tanimoto Sarina
Aug 19, 2026 04:10 PM Form 144 ARS Pharmaceuticals, Filed by: Lowenthal Richard E
Aug 18, 2026 06:05 PM Form 144 ARS Pharmaceuticals, Filed by: Tanimoto Sarina
Aug 18, 2026 05:38 PM Form 144 ARS Pharmaceuticals, Filed by: Lowenthal Richard E
View All Articles

Entities mentioned with SPRY

View All Entities